Psychometric properties of the Neuropathic Pain Scale (NPS) in a knee osteoarthritis population.

Neuropathic pain Osteoarthritis Psychometric properties Total knee replacement Validation

Journal

Osteoarthritis and cartilage open
ISSN: 2665-9131
Titre abrégé: Osteoarthr Cartil Open
Pays: England
ID NLM: 101767068

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 06 07 2019
accepted: 06 01 2020
entrez: 7 12 2022
pubmed: 23 1 2020
medline: 23 1 2020
Statut: epublish

Résumé

Symptoms resembling neuropathic pain (neuropathic-like symptoms) are prevalent in osteoarthritis (OA) populations. Scales that measure neuropathic-like symptoms frequently were established in groups with true neuropathic pain conditions and have not been assessed in OA. We assessed the psychometric properties of the Neuropathic Pain Scale (NPS) in subjects with OA undergoing total knee replacement (TKR). In a prospective study of adults undergoing TKR for OA, we assessed baseline distributions, acceptability (completion rate), internal consistency (Cronbach's alpha), responsiveness 12 months post-TKR, and construct validity of the NPS. We performed factor analysis and created subscales from the items loading onto each retained factor. We evaluated subscale properties and calculated the proportion of total scores attributable to each subscale and compared this with the proportion expected if each item contributed equally. Mean baseline NPS score among 263 participants was 42.7 (SD: 15.9). Cronbach's alpha was 0.88. Factor analysis produced two factors: "bothersome" (items: intense/sharp/dull/unpleasant/deep; Cronbach's alpha = 0.87), and "dysesthetic" (items: cold/sensitive/itchy/surface; alpha = 0.77). Bothersome items contributed more to total NPS scores (74%) than would be expected if each item contributed equally (50%). NPS scores correlated moderately with baseline pain and function, and decreased after TKR, with standardized response means (SRMs) of: total NPS: 1.77, Bothersome subscale: 2.03, Dysesthetic subscale: 0.70. The NPS had acceptable completion, internal consistency, and construct validity, but was not optimal for use in OA; Bothersome subscale items disproportionately drive total NPS scores and may fail to discriminate between nociceptive and neuropathic-like symptoms.

Identifiants

pubmed: 36474559
doi: 10.1016/j.ocarto.2020.100027
pii: S2665-9131(20)30011-X
pmc: PMC9718093
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100027

Informations de copyright

© 2020 The Authors.

Déclaration de conflit d'intérêts

The authors declare that there are no conflicts of interest.Appendix Fig. 1a–b. Factor 1/Bothersome subscale scores (0–100 scale) at baseline and 12 months after TKR.Appendix Fig. 1Appendix Fig. 2a–b. Factor 2/Dysesthetic subscale scores (0–100 scale) at baseline and 12 months after TKR.2Appendix Fig. 2Appendix Table 1Subscale item-to-item and corrected item-to-total correlations (Pearson)Appendix Table 1Factor 1 subscaleIntenseSharpDullUnpleasantDeepTotal subscale scoreAlpha with item deleted*Intense1.000.680.490.810.740.830.82Sharp0.681.000.320.610.660.660.86Dull0.490.321.000.470.460.490.90Unpleasant0.810.610.471.000.740.790.82Deep0.740.660.460.741.000.790.82Factor 2 subscaleColdSensitiveItchySurfaceTotal subscale scoreAlpha with item deleted†Cold1.000.460.480.330.500.74Sensitive0.461.000.630.460.650.67Itchy0.480.631.000.460.670.67Surface0.330.460.461.000.500.77*Subscale Cronbach's alpha with all items = 0.87.†Subscale Cronbach's alpha with all items = 0.77.Appendix Table 2Correlations of NPS and NPS subscales with baseline pain, function, and psychosocial measures (Pearson unless otherwise noted; Estimate (95% CI)Appendix Table 2NPS scoreFactor 1 subscale†Factor 2 subscale‡MHIWOMAC painWOMAC functionPCS scoreNPS score–Factor 1 subscale†0.89 (0.87–0.92)–Factor 2 subscale‡0.83 (0.79–0.87)0.52 (0.42–0.61)–MHI−0.31 (−0.42–−0.19)−0.28 (−0.39–0.16)−0.26 (−0.37–−0.14)–WOMAC pain0.66 (0.58–0.72)0.60 (0.51–0.67)0.51 (0.41–0.60)−0.28 (−0.40–−0.16)–WOMAC function0.72 (0.65–0.77)0.68 (0.61–0.74)0.54 (0.45–0.63)−0.31 (−0.42–−0.19)0.77 (0.71–0.82)–PCS score0.40 (0.28–0.51)0.42 (0.30–0.53)0.27 (0.14–0.39)−0.53 (−0.63–−0.43)0.40 (0.28–0.51)0.43 (0.31–0.54)–Pain regions*0.29 (0.17–0.40)0.22 (0.10–0.34)0.25 (0.13–0.36)−0.27 (−0.38–−0.15)0.18 (0.06–0.30)0.24 (0.12–0.36)0.24 (0.10–0.36)*Correlations with pain regions are Spearman correlation coefficients.†The Factor 1 subscale consists of the items intense, sharp, dull, unpleasant, and deep.‡The Factor 2 subscale consists of the items cold, sensitive, itchy, and surface.Appendix Table 3Factor loadings for the 8 NPS-8 items, from the rotated factor pattern matrix and factor structure matrix N = 257Appendix Table 3ItemFactor Pattern†Factor Structure‡Factor 1Factor 2Factor 1Factor 2Sharp0.82*−0.040.80*0.35Hot0.50*0.310.65*0.55*Dull0.390.160.47*0.35Cold0.070.57*0.340.60*Sensitive−0.020.81*0.370.80*Itchy0.000.78*0.370.78*Deep0.84*−0.080.80*0.32Surface0.42*0.380.61*0.59**Asterisk indicates that the item loading on the given factor exceeds 0.4.†In the factor pattern (left), the values are standardized regression coefficients of an item on the factor.‡In the factor structure (right), the values are the product-moment correlations between an item and the factor.

Références

Arthritis Rheum. 2001 Aug;45(4):384-91
pubmed: 11501727
Osteoarthritis Cartilage. 2011 Jun;19(6):647-54
pubmed: 21440077
Psychiatry Res. 2001 Dec 31;105(3):243-53
pubmed: 11814543
J Manipulative Physiol Ther. 2013 Sep;36(7):450-9
pubmed: 23845196
J Rheumatol. 1988 Dec;15(12):1833-40
pubmed: 3068365
Arthritis Res Ther. 2014 Dec 14;16(6):507
pubmed: 25497320
Yonsei Med J. 2012 Jul 1;53(4):801-5
pubmed: 22665349
J Clin Epidemiol. 2007 Jan;60(1):34-42
pubmed: 17161752
Osteoarthritis Cartilage. 2013 Sep;21(9):1236-42
pubmed: 23973136
Neurology. 1997 Feb;48(2):332-8
pubmed: 9040716
Diabet Med. 2012 May;29(5):578-85
pubmed: 22023377
BMJ. 2009 Aug 21;339:b2844
pubmed: 19700505
Clin Pharmacol Ther. 2011 Nov;90(5):737-42
pubmed: 21975345
Semin Arthritis Rheum. 2017 Aug;47(1):1-8
pubmed: 28320529
Arthritis Care Res (Hoboken). 2010 Jul;62(7):1019-23
pubmed: 20589688
Arthritis Res Ther. 2015 Sep 03;17:237
pubmed: 26335941
BMC Neurol. 2011 Aug 23;11:104
pubmed: 21861889
Curr Pain Headache Rep. 2006 Jun;10(3):159-66
pubmed: 18778569
J Pain. 2005 Feb;6(2):98-106
pubmed: 15694876
Arthritis Care Res (Hoboken). 2015 Apr;67(4):519-28
pubmed: 25155472
Osteoarthritis Cartilage. 2017 May;25(5):667-675
pubmed: 27986621
J Pain. 2005 Mar;6(3):149-58
pubmed: 15772908
Curr Med Res Opin. 2006 Oct;22(10):1911-20
pubmed: 17022849
Pain. 1986 Jan;24(1):57-65
pubmed: 2937007
Clin Orthop Relat Res. 2015 Dec;473(12):3894-902
pubmed: 26443774
Anesth Analg. 2018 May;126(5):1763-1768
pubmed: 29481436
Clin J Pain. 2007 Jul-Aug;23(6):473-81
pubmed: 17575486
Pain Pract. 2015 Sep;15(7):618-26
pubmed: 24750662
Curr Med Res Opin. 2004;20 Suppl 2:S13-9
pubmed: 15563742

Auteurs

Emma C Lape (EC)

Orthopaedic and Arthritis Center for Outcomes Research (OrACORe), Brigham and Women's Hospital, Boston, MA, USA.

Faith Selzer (F)

Orthopaedic and Arthritis Center for Outcomes Research (OrACORe), Brigham and Women's Hospital, Boston, MA, USA.
Department of Orthopedic Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Aileen M Davis (AM)

Division of Health Care and Outcomes Research, Krembil Research Institute, University Health Network, Toronto, Canada.
Institute of Health, Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Institute of Rehabilitation Science, University of Toronto, Toronto, Canada.
Department of Physical Therapy, University of Toronto, Toronto, Canada.

Jamie E Collins (JE)

Orthopaedic and Arthritis Center for Outcomes Research (OrACORe), Brigham and Women's Hospital, Boston, MA, USA.
Department of Orthopedic Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Elena Losina (E)

Orthopaedic and Arthritis Center for Outcomes Research (OrACORe), Brigham and Women's Hospital, Boston, MA, USA.
Department of Orthopedic Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.

Jeffrey N Katz (JN)

Orthopaedic and Arthritis Center for Outcomes Research (OrACORe), Brigham and Women's Hospital, Boston, MA, USA.
Department of Orthopedic Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, USA.

Classifications MeSH